Targeted Treatment of Ischemic and Fibrotic Complications of Myocardial Infarction Using a Dual-Delivery Microgel Therapeutic

ACS Nano
Emily MihalkoAshley C Brown

Abstract

Myocardial infarction (MI), commonly known as a heart attack, affects millions of people worldwide and results in significant death and disabilities. A major cause of MI is fibrin-rich thrombus formation that occludes the coronary arteries, blocking blood flow to the heart and causing fibrin deposition. In treating MI, re-establishing blood flow is critical. However, ischemia reperfusion (I/R) injury itself can also occur and contributes to cardiac fibrosis. Fibrin-specific poly( N-isopropylacrylamide) nanogels (FSNs) comprised of a core-shell colloidal hydrogel architecture are utilized in this study to design a dual-delivery system that simultaneously addresses the need to (1) re-establish blood flow and (2) inhibit cardiac fibrosis following I/R injury. These therapeutic needs are met by controlling the release of a fibrinolytic protein, tissue plasminogen activator (tPA), and a small molecule cell contractility inhibitor (Y-27632). In vitro, tPA and Y-27632-loaded FSNs rapidly degrade fibrin and decrease cardiac cell stress fiber formation and connective tissue growth factor expression, which are both upregulated in cardiac fibrosis. In vivo, FSNs localize to fibrin in injured heart tissue and, when loaded with tPA and Y-27...Continue Reading

References

Jul 1, 1987·Progress in Cardiovascular Diseases·L C Becker, G Ambrosio
Sep 2, 1993·The New England Journal of Medicine·UNKNOWN GUSTO investigators
May 21, 1998·Circulation·H D White, F J Van de Werf
Jun 24, 2000·Annals of the New York Academy of Sciences·Z A Fayad, V Fuster
Oct 19, 2000·Methods in Enzymology·S NarumiyaM Uehata
Oct 19, 2004·Journal of the American College of Cardiology·Raymond J GibbonsAllan S Jaffe
Dec 22, 2006·European Journal of Pharmacology·Md Shenuarin Bhuiyan, Kohji Fukunaga
Sep 15, 2007·The New England Journal of Medicine·Derek M Yellon, Derek J Hausenloy
Oct 19, 2007·The New England Journal of Medicine·Brahmajee K NallamothuHarlan M Krumholz
Dec 19, 2007·The Journal of Cell Biology·Pierre-Jean WipffBoris Hinz
Mar 18, 2008·European Journal of Cell Biology·Pierre-Jean Wipff, Boris Hinz
Apr 9, 2008·Journal of the American Chemical Society·Kirsten Overoye-ChanPeter Caravan
Aug 2, 2008·The New England Journal of Medicine·Christophe PiotMichel Ovize
Apr 4, 2009·Bioconjugate Chemistry·William H BlackburnL Andrew Lyon
Oct 1, 2010·Cardiovascular Research·Esther E Creemers, Yigal M Pinto
Oct 12, 2010·Vascular Medicine·Gregory Piazza, Samuel Z Goldhaber
Dec 3, 2010·International Journal of Experimental Pathology·Carol G AuDavid S Winlaw
May 17, 2011·American Journal of Physiology. Heart and Circulatory Physiology·Meimei YinRudolf A de Boer
Dec 21, 2011·Accounts of Chemical Research·Michael H Smith, L Andrew Lyon
Dec 23, 2011·Cell Death & Disease·M ChiongS Lavandero
May 24, 2012·F1000 Medicine Reports·Victor F Tapson
Jul 18, 2012·Proceedings of the American Thoracic Society·Boris Hinz
Jan 3, 2013·The Journal of Clinical Investigation·Derek J Hausenloy, Derek M Yellon
Jan 30, 2014·Journal of Molecular and Cellular Cardiology·Edie C GoldsmithFrancis G Spinale
Nov 15, 2014·Clinical, Cosmetic and Investigational Dermatology·Ian A DarbyAlexis Desmoulière
May 6, 2015·Journal of Visualized Experiments : JoVE·Adam C VandergriffKe Cheng
Jun 21, 2015·American Journal of Physiology. Heart and Circulatory Physiology·Kar Wey YongFeng Xu
Dec 2, 2015·Journal of Molecular and Cellular Cardiology·Sander van PuttenBoris Hinz
Mar 24, 2016·Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology·Jie JianRenbin Huang
Jun 22, 2016·Cell and Tissue Research·Virpi Talman, Heikki Ruskoaho
Jan 27, 2017·Circulation·Emelia J BenjaminUNKNOWN American Heart Association Statistics Committee and Stroke Statistics Subcommittee
Jun 5, 2018·Nature Biomedical Engineering·Junnan TangKe Cheng

❮ Previous
Next ❯

Citations

May 28, 2020·Journal of the American Heart Association·Leon M PtaszekJeremy N Ruskin
Dec 15, 2018·Advanced Healthcare Materials·Ke HuangKe Cheng
Dec 7, 2018·Evidence-based Complementary and Alternative Medicine : ECAM·Tongtong XuXiangwei Lv
Feb 10, 2021·Blood Advances·Emily P MihalkoAshley C Brown
Feb 23, 2019·Experimental Cell Research·Evan L Teng, Adam J Engler
May 14, 2021·Advanced Drug Delivery Reviews·Fabiana PassaroGianluca Testa
May 23, 2021·Macromolecular Rapid Communications·Pabitra SahaAndrij Pich
Jun 3, 2021·Pharmaceutics·Clara Correa-PazFrancisco Campos
Jun 18, 2021·Biomaterials·Paolo Contessotto, Abhay Pandit
Jun 22, 2021·Frontiers in Bioengineering and Biotechnology·Mira ChingaleKe Huang
Mar 13, 2019·ACS Applied Materials & Interfaces·Xuan LiuYuquan Wei
Apr 19, 2019·Langmuir : the ACS Journal of Surfaces and Colloids·Matthias KargWalter Richtering
Oct 8, 2020·ACS Applied Materials & Interfaces·D ChesterA C Brown
Jan 29, 2022·Journal of Cellular and Molecular Medicine·Zenglei ZhangJunnan Tang
Feb 3, 2022·Journal of Biomedical Materials Research. Part a·Daniel ChesterAshley C Brown

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anxiety Disorders

Discover the latest research on anxiety disorders including agoraphobia, panic disorder, obsessive-compulsive disorder, and post-traumatic stress disorder here.

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.